As of 2026-09-15, the Relative Valuation of Aeglea Bio Therapeutics Inc (AGLE) is (1,497.59) USD. This relative valuation is based on P/E multiples. With the latest stock price at 12.01 USD, the upside of Aeglea Bio Therapeutics Inc based on Relative Valuation is -12569.6%.
The range of the Relative Valuation is (1,395.82) - (1,715.69) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 19.2x - 23.6x | 21.4x |
| Forward P/E multiples | 15.9x - 23.7x | 19.8x |
| Fair Price | (1,395.82) - (1,715.69) | (1,497.59) |
| Upside | -11722.1% - -14385.5% | -12569.6% |
| Date | P/E |